The drug "Lerivon". Instructions for its use.

"Lerivon" is a drug related to antidepressants. In order to familiarize yourself with the composition and effect of its components, the instruction is always attached to the Lerivon preparation.

The composition of "Lerivon" includes the active substance of the drug - mianserin hydrochloride (30 mg), as well as the auxiliary components: magnesium stearate, potato starch, melilcellulose, silicon dioxide, kalloid anhydrous, calcium hydrophosphate, titanium dioxide (E 171), macrogol, hypromellose.

The active substance mianserin refers to piperazino-azepine compounds that do not chemically belong to tricyclic antidepressants. "Lerivon" blocks alpha2 receptors and inhibits the reuptake of norepinephrine, thereby strengthening the brain in the noradrenergic transmission. Interactions with serotinic receptors in the central nervous system were also revealed. The drug also has an anxiolytic effect, and it is very important in the treatment of anxiety disorders and sleep disorders, which are caused by the general depressive state of a person.

The instruction attached to the drug "Lerivon" indicates that this medication is well tolerated by patients with diseases of the cardiovascular system, as well as elderly people. In doses that are therapeutically effective, Lerivon has virtually no effect on the cardiovascular system. He does not have anticholinergic activity. It has less cardiotoxic effects in overdose than tricyclic antidepressants. "Lerivon" does not apply to antagonists of antihypertensive and sympathomimetic agents.

The drug "Lerivon" is used for depressions of various etiologies. However, there are several contraindications. In order to familiarize the user with them, the instruction is attached to the drug "Lerivon". After reading it in detail, you can find out that you can not take "Lerivon": with increased sensitivity to the active substance - mianserin or any auxiliary component; Children and adolescents under the age of 18; With liver diseases with a pronounced impairment of its functions.

With caution to take this medicine costs people with renal or hepatic insufficiency, heart failure, closed-angle glaucoma, diabetes, prostatic hypertrophy. With regard to the period of pregnancy and lactation, the instruction attached to the Lerivon preparation provides information on the fact that animal experiments have been carried out and limited data collected for a person. Based on this, it was found that mianserin does not have neonatal or intrauterine harm. It was also found that mianserin is absorbed in human milk in minimal amounts. However, despite this, before taking "Lerivon" during feeding or pregnancy, it is necessary to compare the benefit of the drug with the possible risk for the child and the fetus.

You can read about the drug "Lerivon" reviews, before you directly use the medication. From the reviews you can sometimes get useful information. For example, you can learn about some side effects: often enough sleepiness occurs; Sometimes the body weight increases; Very rare cases of agranulocytosis, reversible development of leukopenia, seizures, arthralgia, gynecomastia, edema, impaired liver function are also described.

The instructions for use applied to the drug "Lerivon" are not intended for self-administration but only for familiarization. It is necessary to take this into account before using the medication. Treatment is prescribed by a doctor.